🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II trial to assess whether IRESSA™ (gefitinib) has anti-tum...
Status
Completed
Location
Multiple Locations
Start Date
2001-04
Trial ID
NCT00632723
Treatments Being Tested
The safety, tolerability and recommended phase 2 dose (RP2D) of the combina...
Status
Completed
Location
National Cancer Centre Singapore
Start Date
2011-10-03
Trial ID
NCT01570296
Treatments Being Tested
This study is being carried out to see if ZD1839 is effective in treating m...
Status
Completed
Location
Research Site
Start Date
2003-10
Trial ID
NCT00229697
The purpose of this study is to provide gefitinib treatment to patients who...
Status
Approved For Marketing
Location
Research Site
Start Date
TBD
Trial ID
NCT00683306
Treatments Being Tested
The purpose of the study is to determine the efficacy of gefitinib (IressaT...
Status
Completed
Location
Research Site
Start Date
2003-02
Trial ID
NCT00238797
Treatments Being Tested
The primary objective of the study is to evaluate the activity of the combi...
Status
Completed
Location
Research Facility
Start Date
2003-07
Trial ID
NCT00242762
Treatments Being Tested
This is a multicentre, randomised (2:1), double blind, non-comparative phas...
Status
Completed
Location
Research Site
Start Date
2002-09
Trial ID
NCT00247481
The purpose of this study is to compare the changes in a proliferation biom...
Status
Completed
Location
Research Site
Start Date
2004-01
Trial ID
NCT00255463
Treatments Being Tested
The primary objective of the Phase I part of the study is to determine the ...
Status
Completed
Location
Research Site
Start Date
2004-02
Trial ID
NCT00242788
Treatments Being Tested
The aim of the study is to determine if Iressa added to radiotherapy is eff...
Status
Withdrawn
Location
Research Site
Start Date
2003-07
Trial ID
NCT00233636
Treatments Being Tested